Viva Biotech provides one-stop services ranging from early-stage structure-based drug R&D to commercial manufacturing for global biopharmaceutical innovators. Established in 2008, Viva Biotech offers drug discovery expertise, integrating dedicated experts, cutting-edge technology platforms, and state-of-the-art equipment.

Viva Biotech

Established in 2008, Viva Biotech (01873.HK) provides one-stop services ranging from early-stage Structure-Based Drug R&D to commercial manufacturing to global biopharmaceutical innovators. We offer leading early-stage to late-phase drug discovery expertise by integrating our dedicated team of experts, cutting-edge technology platforms, and state-of-the-art equipment in X-ray crystallization, Cryo-EM, DEL, ASMS, SPR, HDX, AIDD/CADD, and much more. Our business covers all aspects of therapeutic strategies and drug modalities, including small molecules and biologics across the pharma and biotech spectrum. The experienced chemistry team, led by senior medicinal chemists and drug discovery biologists, provides services for drug design, medicinal chemistry (hit to lead and lead optimization), custom synthesis, chemical analysis and purification, kilogram scale-up, peptide synthesis and corresponding bioassays. With our subsidiary, Langhua Pharma, we offer our worldwide pharmaceutical and biotech partners a one-stop integrated CMC (Chemical, Manufacturing, and Control) service from preclinical to commercial manufacturing. Additionally, Viva embedded an equity for service (EFS) model to high potential startups to address unmet medical needs.

Totient

Temasek Holdings

Danming Fund

Honghui Fund

Beida Biomedical Industry Fund

Viva Ventures Biotech Fund

Ming Bioventures

Xiamen Changrong Investment Management

Yingqi Investment

JMCR Partners

Viva Biotech 

At Viva Biotech, we believe in #innovation. That's why our newly finished headquarters, with 40,000 square meters, features new, state-of-the-art facilities and laboratories. We strive to be the best partner in your #drugdiscovery, development, and production processes.

Are you curious about protein structure services at Viva Biotech? At Viva Biotech, experienced experts collaborate to provide comprehensive discovery biology services and expedite drug discovery.

Delve into the details: https://lnkd.in/gZmcRJac

#proteinstructure #cro #cdmo #sbdd #drugdiscoveryservices #drugdevelopment

We are honored that our subsidiary, Langhua Pharmaceutical, has received the API Development & Innovation Award at the CPHI China 2024. This recognition highlights Viva Biotech’s excellence in CDMO services. 

Learn more: https://lnkd.in/gnApkmCC

#CPHIChina #cdmo #API #vivabiotech #langhuapharmaceutical #PharmaInnovation #cro

Are you working with PROTACs? 

Elevate your drug discovery with Viva Biotech’s one-stop PROTAC services. Click on the image to explore our high-quality, efficient, and reliable support.

📢 Don't miss our upcoming PROTAC webinar! Register now to be part of this exciting event: https://lnkd.in/eAMH24CM

#protac #protacs #medchem #proteindegradation #undruggabletargets #cro #cdmo #vivabiotech #drugdiscovery #drugdevelopment

Join us for an enlightening webinar, this session will delve into cutting-edge strategies in PROTACs. Hear from leading experts Michael R.，David Taddei, Jean-Marc Garnier as they unveil their insights into Linkerology, case studies in PROTAC development, and structure-guided optimization strategies. 

Mark your calendars, the date is set! Register now and be part of the revolution in drug discovery!

Here is the registration link: https://lnkd.in/eAMH24CM

#PROTAC #PROTACs #medchem #proteindegradationresearch #proteindegradationstrategy #proteindegradation #molecularglues #PROTACLinkers #compchem #drugdevelopment  #drugdiscovery #cro #cdmo #BiotechInnovation

We're delighted to share that our V-DEL platform poster presentation at SABPA the 8th Annual Frontiers in Therapeutics and Diagnostics (FTD) was awarded the “Excellence Award” last month! This recognition marks the first time we've showcased our DEL platform poster at a conference and underscores our commitment to innovative technology. Additionally, our team had the pleasure of hosting a Lunch and Learn workshop at the FTD Forum in San Diego. Our experts, Yinghong Gao, highlighted our cutting-edge V-DEL platform as part of our comprehensive, one-stop drug discovery platforms. Meanwhile, Jianguo Ma showcased Zhejiang Langhua Pharmaceutical Co., Ltd.'s CDMO services, capturing significant attention.
 
Curious to learn more about our hit discovery platforms? Reach out to us at marketing@vivabiotech.com for further details. At Viva Biotech, we're dedicated to accelerating your drug discovery journey, from SBDD to commercial manufacturing.

#cro #cdmo #del #drugdiscovery #sbdd #biotech #FTD #sabpa #drugdevelopment #bioresearch #biopharmaceuticals

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 10, 2024 7:39 AM	0a7272f1
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Aug 10, 2024 7:39 AM	2cdcfbee
translate crunchbase fundingrounds	general
peers	general	Aug 10, 2024 7:39 AM	65784e7e
news basic	general	Aug 10, 2024 7:39 AM	a7e7df82
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

VIVA

COM:VIVABIOTECH

Viva Biotech